Biovian showing ‘gene to finished vial’ solutions at BIO-Europe 2018
Press Release | Biovian Ltd
OCTOBER 25, 2018
Turku, Finland: – Specialist biopharmaceutical CDMO Biovian will present its full spectrum of ‘gene to finished vial’ contract development and manufacturing offers at one of Europe’s leading biotech partnering events, BIO-Europe 2018 in Copenhagen.
The Biovian stand, at Booth 77 at Copenhagen’s Bella Center, will display its latest portfolio of full range cGMP contract manufacturing services for mammalian, microbial and viral vector production, cell banking and storage, aseptic fill & finish, process development services and quality control.
Formulation, fermentation and purification
The Biovian team, including Eero Mustalahti, Sales Manager, CEO Dr. Knut Ringbom and Director of Business Development and Projects, Antti Nieminen, will be available at the booth and for in-depth discussions with delegates, using the various networking and partnering platforms offered at the conference, including EBD’s PartneringONE online system.
Clinical trial manufacturing expertise
“We are delighted to be returning to the BIO-Europe meeting, which put us in touch with leading drug development companies across Europe,” said Dr. Ringbom.
“Once again, it will give us great opportunities to discuss our very distinctive full-range cGMP offers for drug developers looking for CDMO services of very high quality and responsiveness, particularly when it comes to clinical trial material manufacturing,” Dr. Ringbom added.
Biovian Ltd. is a one-stop-shop Contract Development and Manufacturing Organization (CDMO) specializing in full-process development and manufacture that extends ‘from gene to finished vial’.
Biovian offers Good Manufacturing Practice compliant (cGMP) services from its 4000 square meter facilities in Turku, Finland, that are EMA certified and FDA inspected for production of investigational and commercial products.
The CMO has more than a decade’s successful track record in pharmaceutical contract manufacturing ranging over a wide variety of different biopharmaceutical projects. Biovian GMP services include microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish, analytical quality control, stability studies and virus & cell banking. It also offers labelling, packaging, storage and QP release services.
Biovian also provides development services that cover process and analysis.
About BIO-Europe 2018
The BIO-Europe® Conference is Europe’s largest partnering event serving the global biotechnology industry, providing life science companies with high caliber knowledge sharing and partnering opportunities.
The 24th BIO-Europe Conference is a three-day event opening November 5 at the Bella Center, Copenhagen.
BIO-Europe 2018 will attract more than 4,000 industry attendees from some 60 countries, representing more than 2,100 companies for three days of high-level networking. Partnering is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners, and identify and pre-arrange private one-to-one meetings with multiple company targets.
BIO-Europe is organized by EBD Group and KNECT 365 with further information at: https://ebdgroup.knect365.com/bioeurope/about-bio-europe.
Name: Antti Nieminen, Director, Business Development and Projects, Biovian Ltd.
Tel: +358 40 502 1332